Mirae Asset Global Investments’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.5K Buy
1,076
+82
+8% +$3.9K ﹤0.01% 1260
2025
Q4
$37.1K Buy
994
+207
+26% +$8.41K ﹤0.01% 1456
2025
Q3
$31.8K Hold
787
﹤0.01% 1422
2025
Q2
$20.1K Buy
787
+106
+16% +$2.31K ﹤0.01% 1399
2025
Q1
$14.6K Buy
681
+3
+0.4% +$67 ﹤0.01% 1425
2024
Q4
$14.3K Sell
678
-58
-8% -$1.34K ﹤0.01% 1471
2024
Q3
$16.2K Buy
736
+129
+21% +$2.49K ﹤0.01% 1459
2024
Q2
$10.4K Buy
+607
New +$9.76K ﹤0.01% 1461

Other funds holding PAHC

Mirae Asset Global Investments's PAHC Position: Q1 2026 in Review

Mirae Asset Global Investments increased its Phibro Animal Health (PAHC) stake by 8.2% in Q1 2026, buying an estimated $3.9K and bringing the position to 1,076 shares worth $59.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1260.

Mirae Asset Global Investments first reported a position in PAHC in Q2 2024 and has held it in 8 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Mirae Asset Global Investments held 1,076 shares of Phibro Animal Health worth $59.5K as of Q1 2026.
  • Mirae Asset Global Investments bought 82 Phibro Animal Health shares in Q1 2026, an estimated $3.9K.
  • Phibro Animal Health made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q1 2026, its #1260 holding.
  • Mirae Asset Global Investments first reported a position in Phibro Animal Health in Q2 2024 and has held it in 8 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.